No Data
Anteris Technologies Reports Positive One-Year Results for Patients Treated With Transcatheter Heart Valve System
Lake Street Remains a Buy on Anteris Technologies Global Corp. (AVR)
Press Release: Anteris Reports 2024 Financial Results and Provides Corporate Update
Anteris Technologies 2024 Financials Strong Following Nasdaq Debut, With Plans for Heart Valve Pivotal Trial This Year | ASX:AVR, NASDAQ:AVR
Anteris Technologies Global Corp: 2024 Financial Results and Corporate Update
Anteris Technologies Global Corp: Annual Report to shareholders